Fatma Basak Tanoglu

Fatma Basak Tanoglu

Auto-generated profile, based on publicly available information

Fatma Basak Tanoglu

Department of Obstetrics and Gynecology, Acibadem Taksim Hospital

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2025 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Open access
PDF file
FAFaruk Abike
Faruk Abike
FTFatma Basak Tanoglu
Fatma Basak Tanoglu
GSGuliz Sidar
Guliz Sidar
Deep infiltrative endometriosis (DIE) is characterized by the infiltration of endometrial tissue into the pelvic organs, such as the rectovaginal septum, utero-ovarian, and uterosacral ligaments. Bowel involvement occurs in approximately 3.8–37% of cases, whereas urinary tract involvement is less common (1–6%). The pathophysiology of DIE includes deep infiltration of endometrial tissue into the peritoneum, with the gastrointestinal system being a common site. The pathogenesis of endometriosis involves hormonal functional changes in estrogen and progesterone receptors and the influence of immune factors like peritoneal macrophages, natural killer cells, and lymphocytes. Diagnostic methods, including transvaginal ultrasonography (TVUS) and magnetic resonance imaging (MRI), play crucial roles in identifying and assessing endometriosis. Medical treatment options include oral contraceptives, progesterone pills and devices, and gonadotropin-releasing hormone (GnRH) analogs or antagonists. Surgical treatment options are shave excision, disc excision, and colorectal resection. This review provides a comprehensive overview of DIE, its pathophysiology, diagnostic methods, treatment options, as well as implications for fertility and pregnancy outcomes.

1 January 2021 in Medical Bulletin of Haseki
Verified
Journal Article
Closed access
AKAyse Filiz Gökmen Karasu
Ayse Filiz Gökmen Karasu
CSCigdem Sahbaz
Cigdem Sahbaz
ZEZeynep Filiz EREN
Zeynep Filiz EREN
TTTaha Takmaz
Taha Takmaz
HÇHalime Çalı
Halime Çalı
BTBaşak Tanoğlu
Başak Tanoğlu

2 June 2023 in International Urogynecology Journal
Verified
Journal Article
Closed access
PDF file
AKAyse Filiz Gokmen Karasu
Ayse Filiz Gokmen Karasu
CCCaglar Cetin
Caglar Cetin
OPOzge Pasin
Ozge Pasin
MKMelike Karacabay
Melike Karacabay
FTFatma Basak Tanoglu
Fatma Basak Tanoglu
GIGulsah Ilhan
Gulsah Ilhan

9 January 2024 in Gynecological Endocrinology
Verified
Journal Article
Open access
CCCaglar Cetin
Caglar Cetin
SOSabri Berkem Okten
Sabri Berkem Okten
OTOlgu Enis Tok
Olgu Enis Tok
PÖPınar Özcan
Pınar Özcan
AKAyse Filiz Gokmen Karasu
Ayse Filiz Gokmen Karasu
SASeda Ates
Seda Ates
To assess the impacts of Platelet-Rich Plasma(PRP) and Granulocyte Colony-Stimulating Factor(G-CSF) on a rat model with induced ovarian follicular damage caused by cyclophosphamide(Cy). Forty-two Sprague-Dawley rats were randomly allocated into seven distinct groups as; Group 1(control): NaCl intraperitoneal (IP) injection was administered on days D1, D7, and D14. Group 2(Cy):Cy IP injection on D1 + NaCl IP injection on D7 and D14 were administered. Group 3(PRP): PRP IP injection on D1,D7 and D14 were administered. Group 4(Cy + PRP):Cy IP injection on D1 and PRP IP injection on D1, D7 and D14 were administered. Group 5(G-CSF): G-CSF IP injection on D1, D7 and D14 were administered. Group 6(Cy + G-CSF):Cy IP injection on D1+ G-CSF IP injection on D1, D7 and D14 were administered. Group 7(Cy + PRP + G-CSF):Cy IP injection on D1+ PRP IP injection on D1,D7 and D14+ G-CSF IP injection on D1,D7 and D14 were administered. Follicular number, histological scores of AMH and INSL3 stained follicles at different stages of follicular development, and serum Anti-Müllerian hormone(AMH) were evaluated. The primary, secondary, and antral follicle intensity scores for AMH-positive staining were most prominent in Groups 3 and 5. There was no significant difference between groups 4, 6 and 7 compared to group 1 in terms of follicule counts and AMH staining. The intensity scores of AMH-positive staining follicles were notably reduced in group 2 compared to groups 4, 6, and 7, with a significant difference (p < .01). Among the groups, group 2 exhibited the least intense antral follicle staining for INSL3, displaying a significant difference(p < .01) compared to the remaining groups. Autologous PRP and G-CSF might protect ovarian function in the face of ovarian damage caused by Cy-induced effects.

29 July 2023 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
IYIrem Yetik
Irem Yetik
FTFatma Basak Tanoglu
Fatma Basak Tanoglu
OPOzge Pasin
Ozge Pasin
CCCaglar Cetin
Caglar Cetin
PÖPınar Özcan
Pınar Özcan

11 November 2024 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Open access
SMShamsi Mehdiyev
Shamsi Mehdiyev
FTFatma Basak Tanoglu
Fatma Basak Tanoglu
EAEsma Demir Altuncu
Esma Demir Altuncu
EOEngin Oral
Engin Oral
Spontaneous hemoperitoneum in pregnancy (SHIP) is defined as sudden, nontraumatic intraperitoneal bleeding that occurs during pregnancy or up to 42 days postpartum. The incidence ranges between 4 and 4.9 per 100 000 births. Although seen rarely, it is associated with perinatal morbidity and mortality due to maternal hemodynamic instability. Endometriosis was shown to be present in 71% of SHIP cases. A 30‐year‐old primigravid woman with a spontaneous conception, at 29 weeks of gestation, presented to our obstetrics and gynecology emergency department with complaints of abdominal and back pain. In terms of her medical history, a laparoscopic cystectomy was performed in August 2022 due to a 90 mm × 50 mm endometrioma in the right ovary. However, deep endometriosis and adenomyosis were not observed. After decelerations appeared on the non‐stress test, the repeat hemoglobin values dropped to 7.2 g/dL, with blood pressure at 70/50 mm Hg and a pulse rate of 95/min. The decision was made for laparotomy and emergency delivery of the baby. It is crucial to consider SHIP, especially in pregnant patients with a history of endometriosis surgery. Managing such high‐risk cases in specialized centers and easily identifying predisposing factors for SHIP can lead to improved outcomes, despite its rarity and poor prognosis.